VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BGLC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BGLCBioNexus Gene Lab Corp.
$2.03$4M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBGLCQuarterly Financials

BioNexus Gene Lab Corp. (BGLC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

BioNexus Gene Lab Corp. (BGLC) quarterly income statement — complete revenue, gross profit & net income history

BGLC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue22.84K483.76K2.54M2.26M2.14M2.52M2.63M1.97M2.38M2.27M2.55M2.57M2.38M2.84M2.58M2.49M3.03M3.25M3.58M3.09M
Revenue Growth %-98.93%-80.83%-3.29%14.47%-10.28%11.03%3%-23.07%0.2%-19.95%-0.83%3.29%-21.52%-12.5%-27.99%-19.63%-12.18%-71.43%15.69%180.21%
Cost of Goods Sold45.57K487.74K2.17M1.89M1.79M2.21M2.3M1.69M2.02M2.01M2.2M2.23M2.01M2.5M2.28M2.24M2.7M2.79M2.89M2.62M
COGS % of Revenue199.51%100.82%85.15%83.72%83.93%87.75%87.59%85.38%84.67%88.27%86.12%86.77%84.48%88.05%88.37%90.21%88.99%85.96%80.76%84.88%
Gross Profit-22.73K-3.98K377.69K368.02K343.49K309.23K326.54K288.72K365.03K266.56K354.33K339.71K368.9K339.23K299.5K243.32K333.54K455.55K688.1K467.61K
Gross Margin %-99.51%-0.82%14.85%16.28%16.07%12.25%12.41%14.62%15.33%11.73%13.88%13.23%15.52%11.95%11.63%9.79%11.01%14.04%19.24%15.12%
Gross Profit Growth %-106.62%-101.29%15.66%27.47%-5.9%16.01%-7.84%-15.01%-1.05%-21.42%18.31%39.62%10.6%-25.53%-56.47%-47.96%-42.75%-73.75%31.76%193.56%
Operating Expenses548.7K1.03M1.08M979.32K961.91K725.45K1.66M29.55K444.06K9.85K2.88M611.91K419.53K461.92K364.71K381.29K298.85K254.49K315.46K327.62K
OpEx % of Revenue2402.16%212.51%42.46%43.33%45.01%28.74%63.27%1.5%18.64%0.43%112.89%23.84%17.65%16.27%14.16%15.34%9.87%7.84%8.82%10.6%
Selling, General & Admin534.22K1.01M-105.88K1.13M-148.82K469.4K2.13M759.66K469.67K-15.91K3.08M807.08K536.87K487.86K418.82K434.12K345.24K161.21K362.31K378.05K
SG&A % of Revenue2338.74%209.09%-4.16%49.78%-6.96%18.6%80.97%38.47%19.72%-0.7%120.65%31.44%22.58%17.18%16.26%17.47%11.4%4.97%10.13%12.23%
Research & Development14.49K11.1K14.88K12.56K12.14K47.51K08.2K11.47K54.98K0000000000
R&D % of Revenue63.42%2.29%0.58%0.56%0.57%1.88%-0.42%0.48%2.42%----------
Other Operating Expenses05.41K1000K-158.46K1000K208.54K-465.53K-738.3K-37.08K-29.23K-198.24K-195.16K-117.34K-25.94K-54.11K-52.84K-46.39K93.27K-46.85K-50.43K
Operating Income-571.43K-1.03M-702.51K-611.29K-618.42K-416.22K-1.34M259.17K-79.03K256.71K-2.53M-272.2K-50.63K-122.69K-65.22K-137.96K34.69K201.06K372.64K139.99K
Operating Margin %-2501.68%-213.33%-27.62%-27.05%-28.94%-16.49%-50.85%13.13%-3.32%11.29%-99.01%-10.6%-2.13%-4.32%-2.53%-5.55%1.15%6.2%10.42%4.53%
Operating Income Growth %7.6%-147.95%47.48%-335.87%-682.53%-262.14%47.1%195.21%-56.09%309.23%-3777.19%-97.3%-245.95%-161.02%-117.5%-198.55%-89.86%-86.1%57.03%512.05%
EBITDA-527.55K-988.8K-659.15K-569.56K-578.4K-373.19K-1.29M290.63K-49.44K286.36K-2.5M-247.59K-25.76K-96.63K-39.38K-111.08K61.34K227.58K399.46K179.82K
EBITDA Margin %-2309.57%-204.4%-25.91%-25.2%-27.06%-14.79%-48.99%14.72%-2.08%12.6%-97.87%-9.65%-1.08%-3.4%-1.53%-4.47%2.03%7.01%11.17%5.82%
EBITDA Growth %8.79%-164.96%48.85%-295.98%-1069.85%-230.32%48.44%217.38%-91.92%396.34%-6246.1%-122.89%-142%-142.46%-109.86%-161.78%-82.83%-84.92%59.37%929.15%
D&A (Non-Cash Add-back)43.88K43.2K43.35K41.73K40.02K43.02K49.08K31.46K29.59K29.66K29.29K24.61K24.87K26.06K25.83K26.88K26.65K26.52K26.82K39.83K
EBIT-540.49K-1.03M-708.99K-611.29K-586.94K-416.22K-1.34M259.17K-79.03K256.71K-2.53M-272.2K-50.63K-122.69K-65.22K-137.96K34.69K201.06K372.64K139.99K
Net Interest Income14.09K6.5K20.78K24.89K18.66K141.83K-6.19K-4.48K24.32K-4.18K-4.26K-3.04K-2.44K-4.76K-2.07K-2.32K-3.33K-3.99K-2.15K-3.45K
Interest Income17.18K9.77K20.78K29.77K23.57K147.64K0028.98K00000000000
Interest Expense3.08K3.27K04.88K4.91K5.81K6.19K4.48K4.66K4.18K4.26K3.04K2.44K4.76K2.07K2.32K3.33K3.99K2.15K3.45K
Other Income/Expense27.86K-4.12K-6.48K-4.88K-4.91K-5.81K-6.19K-4.48K-4.66K-4.18K-4.26K-3.04K-2.44K-4.76K-2.07K-2.32K-3.33K-3.99K-2.15K-3.45K
Pretax Income-543.58K-1.04M-708.99K-616.17K-623.33K-422.03K-1.34M254.69K-83.69K252.53K-2.53M-275.24K-53.08K-127.45K-67.29K-140.28K31.36K197.08K370.49K136.54K
Pretax Margin %-2379.72%-214.18%-27.87%-27.26%-29.17%-16.72%-51.09%12.9%-3.51%11.11%-99.18%-10.72%-2.23%-4.49%-2.61%-5.64%1.04%6.07%10.36%4.42%
Income Tax00000-73.71K1.55K55.58K20.07K-54.89K76.42K-15.99K15.99K29.52K10.11K-1.62K14.3K107.83K75.17K108.28K
Effective Tax Rate %0%0%0%0%0%17.47%-0.12%21.82%-23.98%-21.74%-3.02%5.81%-30.13%-23.16%-15.03%1.16%45.59%54.72%20.29%79.3%
Net Income-543.58K-1.04M-708.99K-616.17K-623.33K-348.32K-1.35M199.1K-103.76K307.42K-2.61M-259.25K-69.07K-156.97K-77.4K-138.66K17.07K89.24K295.32K28.26K
Net Margin %-2379.72%-214.18%-27.87%-27.26%-29.17%-13.8%-51.15%10.08%-4.36%13.52%-102.17%-10.1%-2.91%-5.53%-3.01%-5.58%0.56%2.75%8.26%0.91%
Net Income Growth %12.79%-197.46%47.3%-409.47%-500.76%-213.31%48.44%176.8%-50.23%295.85%-3271%-86.97%-504.7%-275.89%-126.21%-590.63%-94.96%-92.97%25.96%178.85%
Net Income (Continuing)-543.58K-1.04M-708.99K-616.17K-623.33K-348.32K-1.35M199.1K-103.76K307.42K-2.61M-259.25K-69.07K-156.97K-77.4K-138.66K17.07K89.24K295.32K28.26K
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.22-0.53-0.39-0.34-0.35-0.19-0.750.11-0.060.17-1.56-0.02-0.00-0.01-0.01-0.010.000.010.020.00
EPS Growth %37.14%-178.95%48%-409.09%-496.25%-211.76%51.92%714.53%-1674.07%-----125.6%--94.94%131.19%-24.45%-
EPS (Basic)-0.22-0.53-0.39-0.34-0.35-0.19-0.750.11-0.060.17-1.56-0.02-0.00-0.01-0.01-0.010.000.010.020.00
Diluted Shares Outstanding2.42M1.86M1.8M1.8M1.8M1.8M1.8M1.77M1.77M1.77M1.68M1.45M1.45M1.45M1.45M1.44M1.43M1.43M1.43M1.43M
Basic Shares Outstanding2.42M1.86M1.8M1.8M1.8M1.8M1.8M1.77M1.77M1.77M1.68M1.45M1.45M1.45M1.44M1.43M1.43M1.43M1.43M1.43M
Dividend Payout Ratio--------------------